作者
Samantha Pollard, Deirdre Weymann, Brandon Chan, Morgan Ehman, Sarah Wordsworth, James Buchanan, Timothy P Hanna, Cheryl Ho, Howard J Lim, Paula K Lorgelly, Adam JN Raymakers, Christopher McCabe, Dean A Regier
发表日期
2022/8/1
来源
Value in Health
卷号
25
期号
8
页码范围
1371-1380
出版商
Elsevier
简介
Objectives
Precision oncology is generating vast amounts of multiomic data to improve human health and accelerate research. Existing clinical study designs and attendant data are unable to provide comparative evidence for economic evaluations. This lack of evidence can cause inconsistent and inappropriate reimbursement. Our study defines a core data set to facilitate economic evaluations of precision oncology.
Methods
We conducted a literature review of economic evaluations of next-generation sequencing technologies, a common application of precision oncology, published between 2005 and 2018 and indexed in PubMed (MEDLINE). Based on this review, we developed a preliminary core data set for informal expert feedback. We then used a modified-Delphi approach with individuals involved in implementation and evaluation of precision medicine, including 2 survey rounds followed by a final voting …
学术搜索中的文章
S Pollard, D Weymann, B Chan, M Ehman… - Value in Health, 2022
